Insider Sellers Might Regret Selling Neuronetics Shares at a Lower Price Than Current Market Value
Neuronetics, Inc.’s (NASDAQ:STIM) value has fallen 12% in the last week, but insiders who sold US$1.6m worth of stock over the last year have had less success. Insiders might have been better off holding onto their shares, given that the average selling price of US$3.84 is still below the current share price.
Although we don’t think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.
The Last 12 Months Of Insider Transactions At Neuronetics
In the last twelve months, the biggest single sale by an insider was when the Executive VP,…
